#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metachromatic leukodystrophy Hereditary angioedema Lymphangioma Bone marrow disorder Hepato-lenticular degeneration Hypersomnia Short stature Cryoglobulinaemia Immune-mediated enterocolitis Neonatal alloimmune thrombocytopenia Neonatal asphyxia Glomerulonephritis minimal lesion Diffuse large B-cell lymphoma refractory Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Anaplastic large cell lymphoma T- and null-cell types More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I Glomerulonephritis membranous Toxic epidermal necrolysis – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Undifferentiated sarcoma – Life with Disease Sjogren’s syndrome – Trials in Disease Myxofibrosarcoma – Life with Disease Turner’s syndrome – Trials in Disease Thrombotic thrombocytopenic purpura – Treatment Mantle cell lymphoma stage III More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lactic Acid MAPLIRPACEPT MRNA-1345 A/(H3N2)-LIKE VIRUS ANTIGEN Ltx-315 Letetresgene Autoleucel Festuca Rubra Pollen GS-1720 Glofitamab Radotinib Dihydrochloride Cldn6 Car-T Ict01 Terlipressin Acetate AVTX-009 NAVENIBART Elacestrant Oxytocin Synthetic SILYMARIN Tepotinib Clemastine Fumarate More therapies…

    Learn about Your Condition

    Type 2 diabetes mellitus Endolymphatic hydrops Retinal neovascularisation Undifferentiated sarcoma Vulval cancer Bronchopulmonary aspergillosis Supranuclear palsy Infertility male Juvenile spondyloarthritis Drug dependence Hyperphagia Carpal tunnel syndrome Mucopolysaccharidosis Perthes disease Chronic disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Long-term Safety of NVDX3 Implant for Patients with Distal Radius Fracture or Low-grade Degenerative Lumbar Spondylolisthesis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Radius fracture
    Investigated Drugs:
    • Nvdx3
    Luxembourg

  • Study on Mifamurtide with Chemotherapy for Patients with High-Risk Osteosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteosarcoma metastatic
    • Osteosarcoma
    Investigated Drugs:
    • Mifamurtide
    • Ifosfamide
    • Cisplatin
    France

  • Study of Chemoradiation with Carboplatin and Paclitaxel for Elderly Patients with Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    France

  • Study on Regorafenib for Patients with Recurrent Grade 2 and 3 Meningioma After Surgery and Radiotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Meningioma malignant
    Investigated Drugs:
    • Regorafenib
    Italy

  • Study on Bupivacaine Hydrochloride and Sodium Chloride for Recovery After Minimally Invasive Colorectal Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bupivacaine Hydrochloride, Anhydrous
    • Sodium Chloride
    The Netherlands

  • Study on the Safety and Effects of Lutetium (177Lu) rhPSMA-10.1 Injection in Men with Advanced Prostate Cancer

    Recruiting

    1 1 1
    Investigated Drugs:
    • 177Lu-Rhpsma-10.1
    Belgium Germany The Netherlands
Previous Page
1 … 524 525 526 527 528 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!